Today, Merck announced that it has significantly expanded the number of Merck medicines available through its Merck Helps™ patient assistance programs, which include the Merck Patient Assistance ...

On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...

You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...

The Department of Health and Human Services Office of Inspector General (OIG) has issued a long-awaited, favorable advisory opinion regarding certain single-donor rare disease state patient assistance ...

Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...

When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass the insurer and access the drug at ...

The high cost of prescription eye medications affects over 2 million Americans dealing with vision problems. Patient Assistance Programs (PAPs) offer a vital solution for the underinsured and ...

One of the most powerful components of the Affordable Care Act (ACA) was the mandate that nonprofit hospitals provide an income-based financial assistance program. But 10 years after the passage of ...

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention. A ...

Associations of Financial Hardship and Health Status, Social Functioning, and Mental Health Among Cancer Survivors in the United States: Findings From a Nationally Representative Study Ulman ...